Literature DB >> 32184095

COX-2 in liver fibrosis.

Hu Yang1, Yang Xuefeng2, Wu Shandong3, Xiao Jianhua4.   

Abstract

As a vital inducible sensor, cyclooxygenase-2 (COX-2) plays an important role in the progress of hepatic fibrogenesis. Activation of hepatic stellate cells (HSCs) in the liver can significantly accelerate the onset and development of liver fibrosis. COX-2 overexpression triggers inflammation that is an important inducer in hepatic fibrosis. Increasing evidence indicates that COX-2 is involved in the main pathogenesis of liver fibrosis, such as inflammation, apoptosis, and cell senescence. Moreover, COX-2 expression is altered in patients and animal models with non-alcoholic fatty liver disease or cirrhosis. These findings suggest that COX-2 has a broad and critical role in the development of liver fibrosis. In this review, we summarize the latest advances in the regulation and signal transduction of COX-2 and its impact on liver fibrosis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; COX-2; Cell senescence; Inflammation; Liver fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32184095     DOI: 10.1016/j.cca.2020.03.024

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2/EP4 pathway.

Authors:  Ying Cao; Weili Mai; Rui Li; Shuwei Deng; Lan Li; Yanxi Zhou; Qiushi Qin; Yue Zhang; Xingang Zhou; Ming Han; Pu Liang; Yonghong Yan; Yu Hao; Wen Xie; Jie Yan; Liuluan Zhu
Journal:  Cell Mol Life Sci       Date:  2022-05-19       Impact factor: 9.261

2.  Phenolic Compounds from Carissa spinarum Are Characterized by Their Antioxidant, Anti-Inflammatory and Hepatoprotective Activities.

Authors:  Ye Liu; Yongli Zhang; Felix Wambua Muema; Festus Kimutai; Guilin Chen; Mingquan Guo
Journal:  Antioxidants (Basel)       Date:  2021-04-23

3.  Integrating Network Pharmacology and Experimental Validation to Investigate the Effects and Mechanism of Astragalus Flavonoids Against Hepatic Fibrosis.

Authors:  Lin An; Yuefang Lin; Leyan Li; Muyan Kong; Yanmei Lou; Jinjun Wu; Zhongqiu Liu
Journal:  Front Pharmacol       Date:  2021-01-22       Impact factor: 5.810

4.  Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway.

Authors:  Siyu Yuan; Can Wei; Guofang Liu; Lijun Zhang; Jiahao Li; Lingling Li; Shiyi Cai; Ling Fang
Journal:  Cell Prolif       Date:  2021-11-22       Impact factor: 6.831

5.  Deciphering the endometrial niche of human thin endometrium at single-cell resolution.

Authors:  Haining Lv; Guangfeng Zhao; Peipei Jiang; Huiyan Wang; Zhiyin Wang; Simin Yao; Zhenhua Zhou; Limin Wang; Dan Liu; Wenbo Deng; Jianwu Dai; Yali Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 11.205

6.  Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation.

Authors:  Zhang Qi; Chen Lan; Ji Xiaofang; Tang Juanjuan; Fu Cheng; Huang Ting; Shen Erxia; Li Zi
Journal:  Parasit Vectors       Date:  2022-04-23       Impact factor: 4.047

Review 7.  Small interfering RNAs in the management of human rheumatoid arthritis.

Authors:  Giuseppe Gargano; Francesco Oliva; Antonio Oliviero; Nicola Maffulli
Journal:  Br Med Bull       Date:  2022-07-09       Impact factor: 5.841

8.  The combination of Lonicerae Japonicae Flos and Forsythiae Fructus herb-pair alleviated inflammation in liver fibrosis.

Authors:  Jing-Bei Zhang; Hong-Liu Jin; Xiao-Ying Feng; Sen-Ling Feng; Wen-Ting Zhu; Hong-Mei Nan; Zhong-Wen Yuan
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

9.  Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology.

Authors:  Rui Qiang; Ya Zhang; Yanhong Wang
Journal:  Dis Markers       Date:  2022-10-04       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.